Treatment of Croup in a 5-Year-Old Child
All children with croup, regardless of severity, should receive a single dose of oral dexamethasone 0.15-0.60 mg/kg (maximum 10 mg), with nebulized epinephrine reserved for moderate-to-severe cases presenting with stridor at rest or significant respiratory distress. 1
Initial Assessment
Immediately evaluate the child for severity indicators:
- Stridor at rest (indicates moderate-to-severe disease requiring epinephrine) 1
- Respiratory rate and work of breathing (retractions, nasal flaring, use of accessory muscles) 1
- Oxygen saturation (hypoxemia if <92-94%) 1
- Ability to speak/cry normally and presence of barking cough 1
- Life-threatening signs: silent chest, cyanosis, fatigue/exhaustion, or poor respiratory effort 1
Radiographic studies are unnecessary and should be avoided unless considering alternative diagnoses such as foreign body aspiration, bacterial tracheitis, or epiglottitis. 1
Treatment Algorithm by Severity
Mild Croup (No Stridor at Rest)
- Administer oral dexamethasone 0.15-0.60 mg/kg (maximum 10 mg) as a single dose 1, 2
- Alternative: prednisolone 1-2 mg/kg (maximum 40 mg) if dexamethasone unavailable 1
- Review in 1 hour for clinical improvement 3
- Provide supportive care with adequate hydration 1
Moderate-to-Severe Croup (Stridor at Rest, Respiratory Distress)
- Give oral dexamethasone 0.15-0.60 mg/kg immediately 1, 2
- Add nebulized epinephrine 0.5 mL/kg of 1:1000 solution (or 4 mL of 1:1000 undiluted for severe cases) 1, 3
- Administer oxygen to maintain saturation ≥94% via nasal cannulae, head box, or face mask 1
- Monitor for at least 2 hours after the last epinephrine dose due to short-lived effect (1-2 hours) and risk of rebound symptoms 1, 2
Hospitalization Criteria
Consider admission when: 1
- Three or more doses of racemic epinephrine are required
- Oxygen saturation <92-94% despite supplemental oxygen
- Age <18 months with moderate-to-severe symptoms
- Respiratory rate >70 breaths/min
- Family unable to provide appropriate observation or supervision
Recent guidelines demonstrate that limiting admission until 3 doses of epinephrine are needed reduces hospitalization rates by 37% without increasing adverse outcomes. 1
Critical Pitfalls to Avoid
- Never discharge within 2 hours of nebulized epinephrine administration due to rebound risk 1, 4
- Never use nebulized epinephrine in outpatient settings where immediate return is not feasible 1
- Never perform blind finger sweeps if foreign body aspiration is suspected, as this may push objects deeper 1
- Avoid agitating the child during examination, as distress can worsen airway obstruction 3
Supportive Care Measures
- Position the child comfortably (neutral head position with roll under shoulders for children <2 years optimizes airway patency) 1
- Maintain adequate hydration and monitor for dehydration 1
- Use antipyretics for fever control and comfort 1
- Humidified or cold air provides no proven benefit and is not recommended 1, 5
- Minimal handling may reduce metabolic and oxygen requirements 1
Discharge Instructions
If discharged home after observation: 1
- Review by primary care provider if deteriorating or not improving after 48 hours
- Educate family on managing fever, preventing dehydration, and recognizing signs of deterioration
- Ensure family is reliable and able to monitor and return if worsening
Special Considerations for Recurrent Croup
If the child has had multiple episodes of croup, consider: 1
- Asthma as differential diagnosis (especially if cough worsens at night, triggered by exercise/irritants, or family history of atopy)
- Anatomic abnormalities requiring flexible bronchoscopy if symptoms are severe, persistent, or atypical
- Prophylactic inhaled corticosteroids may benefit children with recurrent episodes
Antibiotics have no role in uncomplicated viral croup and should not be prescribed. 6, 4